Coal tar
CAS 8007-45-2
Coal tar (CAS 8007-45-2) is a pharmaceutical compound with 0 bioactivity targets and 404 adverse event associations.
Compound Identity
Matched identifiers and naming fields for the pharmaceutical compound record.
Cross-Reference to Cosmetics
Same-CAS ingredient record found in the cosmetics vertical.
Cross-Reference to Chemicals
Same-CAS substance identity is available in the industrial chemicals vertical.
Coal tar is linked to DTXSID1027683 in DSSTox identifiers.
View industrial chemical data →Drug Names / RxNorm
Normalized drug-name vocabulary rows, RxCUIs, and source abbreviations.
| Name | RxCUI | Type | Source |
|---|---|---|---|
| COAL TAR | 2635 | SU | MTHSPL |
| Coal Tar | 2635 | SU | MTHSPL |
| coal tar | 2635 | SU | MTHSPL |
| coal tar | 2635 | IN | RXNORM |
Frequently Asked Questions
Short answers generated only from the same visible source-linked rows on this page.
What is Coal tar used for in pharmaceutical contexts?
Coal tar (CAS 8007-45-2) is rendered as a pharmaceutical compound from the matched source rows; no DailyMed product-name rows are present in this page query.
What are the known adverse events for Coal tar?
Coal tar has 404 DrugCentral/FAERS adverse event associations. Rendered reaction terms include Abdominal discomfort, Adjustment disorder, Affect lability, Anaemia macrocytic, Anaesthesia. Signal rows are source-linked records and should not be read as incidence rates or causality conclusions.
Is Coal tar also used in cosmetics?
Yes. The ingredients table has a same-CAS cosmetic profile for Coal Tar with EU status "prohibited".
What clinical phase is Coal tar in?
No phase 1-4 clinical development badge is rendered for Coal tar because the matched compound identifier rows do not contain a max-phase value.